A Multiple Ascending Dose Study of R1530 in Patients With Advanced Solid Tumors.

NCT00493155 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Hoffmann-La Roche